Fecal microbiota transplantation as a promising treatment option for osteoporosis
- PMID: 36357745
- PMCID: PMC9649400
- DOI: 10.1007/s00774-022-01375-x
Fecal microbiota transplantation as a promising treatment option for osteoporosis
Abstract
Osteoporosis is a systemic metabolic bone disease characterized by the descending bone mass and destruction of bone microstructure, which tends to result in the increased bone fragility and associated fractures, as well as high disability rate and mortality. The relation between gut microbiota and bone metabolism has gradually become a research hotspot, and it has been verified that gut microbiota is closely associated with reduction of bone mass and incidence of osteoporosis recently. As a novel "organ transplantation" technique, fecal microbiota transplantation (FMT) mainly refers to the transplantation of gut microbiota from healthy donors to recipients with gut microbiota imbalance, so that the gut microbiota in recipients can be reshaped and play a normal function, and further prevent or treat the diseases related to gut microbiota disorder. Herein, based on the gut-bone axis and proven regulatory effects of gut microbiota on osteoporosis, this review expounds relevant basic researches and clinical practice of FMT on osteoporosis, thus demonstrating the potentials of FMT as a therapeutic option for osteoporosis and further providing certain reference for the future researches.
Keywords: Fecal microbiota transplantation; Gut microbiota; Osteoporosis; The elderly.
© 2022. The Japanese Society Bone and Mineral Research.
Conflict of interest statement
All the authors declare that they have no potential conflict of interests, nor biomedical financial interests.
Figures



Similar articles
-
Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function.J Orthop Translat. 2022 Sep 26;37:46-60. doi: 10.1016/j.jot.2022.08.003. eCollection 2022 Nov. J Orthop Translat. 2022. PMID: 36196151 Free PMC article.
-
Targeting the gut microbiota-related metabolites for osteoporosis: The inextricable connection of gut-bone axis.Ageing Res Rev. 2024 Feb;94:102196. doi: 10.1016/j.arr.2024.102196. Epub 2024 Jan 12. Ageing Res Rev. 2024. PMID: 38218463 Review.
-
Fecal microbiota transplantation from postmenopausal osteoporosis human donors accelerated bone mass loss in mice.Front Cell Infect Microbiol. 2024 Dec 5;14:1488017. doi: 10.3389/fcimb.2024.1488017. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39703374 Free PMC article.
-
Fecal microbiota transplantation alleviates lipopolysaccharide-induced osteoporosis by modulating gut microbiota and long non-coding RNA TUG1 expression.Front Cell Infect Microbiol. 2025 Apr 11;15:1535666. doi: 10.3389/fcimb.2025.1535666. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40292220 Free PMC article.
-
Fecal microbiota transplantation in cancer management: Current status and perspectives.Int J Cancer. 2019 Oct 15;145(8):2021-2031. doi: 10.1002/ijc.32003. Epub 2018 Dec 30. Int J Cancer. 2019. PMID: 30458058 Free PMC article. Review.
Cited by
-
From gut to bone: deciphering the impact of gut microbiota on osteoporosis pathogenesis and management.Front Cell Infect Microbiol. 2024 Sep 25;14:1416739. doi: 10.3389/fcimb.2024.1416739. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39386168 Free PMC article. Review.
-
The Preventive Effects of Probiotic Prevotella histicola on the Bone Loss of Mice with Ovariectomy-Mediated Osteoporosis.Microorganisms. 2023 Apr 6;11(4):950. doi: 10.3390/microorganisms11040950. Microorganisms. 2023. PMID: 37110373 Free PMC article.
-
Fecal microbiota transplantation in mice improves bone material properties through altered mineral quality.JBMR Plus. 2025 Jul 8;9(9):ziaf115. doi: 10.1093/jbmrpl/ziaf115. eCollection 2025 Sep. JBMR Plus. 2025. PMID: 40861794 Free PMC article.
-
Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism.Front Endocrinol (Lausanne). 2023 Mar 9;14:1109296. doi: 10.3389/fendo.2023.1109296. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36967748 Free PMC article. Review.
-
A new target for treating intervertebral disk degeneration: gut microbes.Front Microbiol. 2024 Nov 29;15:1452774. doi: 10.3389/fmicb.2024.1452774. eCollection 2024. Front Microbiol. 2024. PMID: 39678913 Free PMC article. Review.
References
-
- Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391:230–240. doi: 10.1016/s0140-6736(17)32137-2. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials